Baxter International is working with the FDA to address complaints raised in an agency warning letter regarding the marketing of Baxter's Isolex device used in cancer treatment, company spokeswoman Mavis Prall said.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||